Inhibrx Biosciences Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 1.3M | 0 | 100K | 0 | 100K |
| Cost of Goods Sold | 537K | 564K | 582K | 662K | 675K | 689K | 760K | 475K |
| Gross Profit | -537K | -564K | -582K | 638K | -675K | -589K | -760K | 100K |
| R&D Expenses | 24.7M | 25.3M | 28.5M | 22.3M | 36.9M | 33.4M | 38.2M | 67.6M |
| Operating Expenses | 30.4M | 30.4M | 33.8M | 28.0M | 42.2M | 49.3M | 46.0M | 161.0M |
| Operating Income | -30.9M | -30.9M | -33.8M | -27.4M | -42.9M | -49.9M | -46.8M | -160.9M |
| Other Income / Gains | -2.5M | -1.9M | -1.4M | -1.3M | -410K | 2.1M | 2.9M | 2.02B |
| Net Income | -33.4M | -32.8M | -35.3M | -28.7M | -43.3M | -47.9M | -43.9M | 1.86B |
| EPS (Diluted) | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 | -3.31 | -2.84 | 128.35 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0.491 | 0 | -5.89 | 0 | 1.00 |
| General And Administrative Expenses | 5.7M | 5.6M | 5.3M | 6.4M | 6.0M | 16.7M | 7.9M | 93.4M |
| Selling And Marketing Expenses | -7K | 0 | 0 | 0 | 0 | 0 | -100K | 0 |
| Selling General And Administrative Expenses | 5.7M | 5.6M | 5.3M | 6.4M | 6.0M | 16.7M | 7.8M | 93.4M |
| Other Expenses | 0 | -564K | 0 | -662K | -675K | -689K | 0 | 0 |
| Cost And Expenses | 30.9M | 30.9M | 33.8M | 28.7M | 42.9M | 50.0M | 46.8M | 161.0M |
| Interest Income | 1.0M | 1.3M | 1.8M | 2.1M | 2.3M | 2.0M | 2.9M | 2.7M |
| Interest Expense | 3.5M | 3.2M | 3.2M | 3.1M | 2.7M | 0 | 0 | 5.4M |
| Depreciation And Amortization | 537K | 564K | 583K | 661K | 675K | 689K | 760K | 476K |
| Ebitda | -29.4M | -30.4M | -31.5M | -24.9M | -39.9M | -47.2M | -43.1M | 1.86B |
| Ebitdaratio | 0 | 0 | 0 | -19.115 | 0 | -471.76 | 0 | 19K |
| Operating Income Ratio | 0 | 0 | 0 | -21.068 | 0 | -499.28 | 0 | -2K |
| Income Before Tax | -33.4M | -32.8M | -35.3M | -28.7M | -43.3M | -47.9M | -43.9M | 1.86B |
| Income Before Tax Ratio | 0 | 0 | 0 | -22.04 | 0 | -478.65 | 0 | 19K |
| Income Tax Expense | 0 | 0 | 0 | 2K | 0 | 0 | 0 | 2K |
| Net Income Ratio | 0 | 0 | 0 | -22.042 | 0 | -478.65 | 0 | 19K |
| Epsdiluted | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 | -3.31 | -2.84 | 125.48 |
| Weighted Average Shs Out | 15.6M | 15.5M | 15.5M | 15.5M | 15.5M | 14.5M | 15.5M | 14.5M |
| Weighted Average Shs Out Dil | 15.6M | 15.5M | 15.5M | 15.5M | 15.5M | 14.5M | 15.5M | 14.8M |